HalioDx is an immuno-oncology diagnostic company providing oncologists with diagnostic products and services to guide cancer care and contribute to precision medicine in the era of immuno-oncology. HalioDx executes biomarker studies and companion diagnostic assay development in conformity with regulations and in partnership with biopharmaceutical companies.
HalioDx has an experienced team of more than 165 employees, CLIA-certified laboratories and compliant facilities in Europe and in the US.